Clinic
Mansukh Ghadiya MD INC
Mansukh Ghadiya MD INC was paid $1.09M by Medicaid between Jan 2018 and Nov 2024, across 37 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 72% of everything it billed.
33Billing provider infoMANSUKH GHADIYA MD INC
BAKERSFIELD, CA 93306
BAKERSFIELD, CA 93306
33aNPI1982026886assigned 01/10/2014
33bProvider typePrimary Care Clinic/Center
28Total paid$1.09M
24GClaims38,117
24DCodes billed37
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in California
Rank by total paid#49 of 422
Median peer was paid$25K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61 | $0.00 | |
| 2019 | 983 | $4K | |
| 2020 | 4,460 | $111K | |
| 2021 | 5,255 | $191K | |
| 2022 | 4,559 | $143K | |
| 2023 | 12,899 | $269K | |
| 2024incomplete | 9,900 | $372K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 72% | 18,343 | 9,217 | $781K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 8.0% | 745 | 679 | $87K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.9% | 538 | 537 | $42K |
| 93000 | 3.5% | 1,278 | 1,210 | $39K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 933 | 719 | $25K |
| 17110 | 1.8% | 287 | 171 | $19K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 830 | 735 | $14K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 98 | 98 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 949 | 718 | $12K |
| 92551 | 1.0% | 1,008 | 1,002 | $11K | |
| 90682 | <1% | 129 | 129 | $9K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 64 | 64 | $8K |
25 more codes
| 82948 | <1% | 2,280 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 113 | $5K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 195 | $5K |
| 99173 | <1% | 1,033 | $5K | |
| 90686 | <1% | 172 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 355 | $2K |
| 96127 | <1% | 172 | $977.45 | |
| 17000 | <1% | 28 | $832.24 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 15 | $311.70 |
| 82947 | <1% | 140 | $184.04 | |
| 99490 | Ccm add 20min | <1% | 43 | $172.72 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 14 | $90.20 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $57.48 |
| 3074F | <1% | 1,637 | $42.03 | |
| 3077F | 0% | 562 | $0.00 | |
| 3078F | 0% | 1,723 | $0.00 | |
| 99051 | 0% | 47 | $0.00 | |
| 3008F | 0% | 2,443 | $0.00 | |
| 3079F | 0% | 470 | $0.00 | |
| 3075F | 0% | 311 | $0.00 | |
| 3080F | 0% | 195 | $0.00 | |
| 3044F | 0% | 457 | $0.00 | |
| 36416 | 0% | 308 | $0.00 | |
| 3048F | 0% | 129 | $0.00 | |
| 3049F | 0% | 61 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGHADIYA, MANSUKH (PRESIDENT/CEO)